NCT06317129View on ClinicalTrials.gov

Clinical Feasibility Study of the BariTon™ System in Obese Patients

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

January 31, 2026

Conditions
Obesity
Interventions
DEVICE

Endoscopic gastric restriction and biliodigestive diversion

The BariTon™ is endoscopically implanted.

Trial Locations (1)

Unknown

RECRUITING

Republican Specialized Scientific and Practical Medical Center of Surgery named after V. Vakhidov, Tashkent

Sponsors

Lead Sponsor

BariaTek Medical
All Listed Sponsors
lead

BariaTek Medical

INDUSTRY

NCT06317129 - Clinical Feasibility Study of the BariTon™ System in Obese Patients | Biotech Hunter | Biotech Hunter